Tumour-associated mesenchymal stem/stromal cells: emerging therapeutic targets
2016 · Nature Reviews Drug Discovery · 464 citations
https://doi.org/10.1038/nrd.2016.193
L
Liangyu Lin
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
34
Papers
3.2K
Citations
21
h-index
26
i10-index
Liangyu Lin is an academic researcher from Hunan University of Traditional Chinese Medicine. The author has contributed to research in topics: Immune cells in cancer & Mesenchymal stem cell research & Cancer Cells and Metastasis. The author has an h-index of 21, co-authored 29 publications.
ORCID: 0000-0003-4312-8955Papers by this author
worksSpermidine alleviates experimental autoimmune encephalomyelitis through inducing inhibitory macrophages
2016 · Cell Death and Differentiation · 167 citations
https://doi.org/10.1038/cdd.2016.71
Tumour cell-derived exosomes endow mesenchymal stromal cells with tumour-promotion capabilities
2016 · Oncogene · 80 citations
https://doi.org/10.1038/onc.2016.131
IGF2R-initiated proton rechanneling dictates an anti-inflammatory property in macrophages
2020 · Science Advances · 66 citations
https://doi.org/10.1126/sciadv.abb7389
Macrophages promote pre-metastatic niche formation of breast cancer through aryl hydrocarbon receptor activity
2024 · Signal Transduction and Targeted Therapy · 30 citations
https://doi.org/10.1038/s41392-024-02042-5
Steroids Enable Mesenchymal Stromal Cells to Promote CD8<sup>+</sup> T Cell Proliferation Via VEGF‐C
2021 · Advanced Science · 14 citations
https://doi.org/10.1002/advs.202003712
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat